Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad
1. Hims & Hers faces scrutiny for misleading weight loss advertisement. 2. Lawmakers express concerns over omitted side effects in the ad. 3. Advertisement claims compounded GLP-1s are affordable compared to brand names. 4. Hims & Hers' market cap reached $9.5 billion with significant share price increase. 5. FDA may enforce actions due to potential misleading marketing practices.